Kaye Edward M. MD (CIK 0001522780)

Latest company ownership

Shares held
57,758
Last filed at
Dec 3, 2025
Confidence Score
3.2
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
35,461
Last filed at
Aug 7, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q1 2025Q4
CYTK - CYTOKINETICS INC
Role: Director
Shares held
20,000
Last filed at
Dec 2, 2025
Confidence Score
1.8
2025Q4
Confidence Score History
2020Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 8, 2025 Dec 10, 2025 Stoke Therapeutics, Inc. Director Sell 12.5 -13,430 -21.47% ✓ $433.4K
Dec 3, 2025 Dec 5, 2025 Stoke Therapeutics, Inc. Director Sell 17.5 -15,001 -19.34% ✓ $467K
Dec 1, 2024 Dec 3, 2025 Stoke Therapeutics, Inc. Director Sell 42.5 -2,136 -4.00% ✗ $64.5K
Dec 1, 2025 Dec 2, 2025 CYTOKINETICS INC Director Sell 17.5 -28,064 -73.77% ✗ $1.9M
Nov 11, 2025 Nov 12, 2025 CYTOKINETICS INC Director Sell 20.0 -5,175 -34.15% ✗ $336.8K
Oct 8, 2025 Oct 10, 2025 Stoke Therapeutics, Inc. Director Sell 7.5 -25,000 -33.73% ✓ $750K
Oct 3, 2025 Oct 7, 2025 Stoke Therapeutics, Inc. Director Sell 5.0 -42,461 -46.36% ✓ $1.1M
Oct 6, 2025 Oct 6, 2025 CYTOKINETICS INC Director Sell 20.0 -6,757 -40.86% ✗ $405.4K
Sep 30, 2025 Sep 30, 2025 CYTOKINETICS INC Director Sell 20.0 -6,695 -28.82% ✗ $368.8K
Aug 29, 2025 Sep 3, 2025 Stoke Therapeutics, Inc. Director Sell 5.0 -61,885 -40.32% ✓ $1.2M
Sep 2, 2025 Sep 2, 2025 CYTOKINETICS INC Director Sell 20.0 -6,756 -22.53% ✗ $337.8K
Aug 18, 2025 Aug 20, 2025 Stoke Therapeutics, Inc. Director Sell 42.5 -12,126 -7.32% ✗ $221.2K
Jun 5, 2025 Jun 5, 2025 CYTOKINETICS INC Director Sell 22.5 -3,636 -10.92% ✗ $116.7K
Mar 18, 2025 Mar 20, 2025 Stoke Therapeutics, Inc. Director Sell 42.5 -19,289 -12.16% ✗ $163.7K
Dec 9, 2024 Dec 11, 2024 Stoke Therapeutics, Inc. CEO Sell 42.5 -6,786 -9.88% ✗ $88.2K
Dec 6, 2024 Dec 10, 2024 Stoke Therapeutics, Inc. CEO Sell 42.5 -6,170 -8.24% ✗ $78.8K
May 20, 2024 May 22, 2024 Stoke Therapeutics, Inc. CEO Sell 7.5 -42,350 -61.07% ✓ $653.5K
Mar 15, 2024 Mar 19, 2024 Stoke Therapeutics, Inc. CEO Sell 42.5 -11,150 -13.85% ✗ $68K
Aug 5, 2022 Aug 8, 2022 CYTOKINETICS INC Director Sell 7.5 -11,428 -47.61% ✓ $571.4K
Dec 23, 2021 Dec 23, 2021 CYTOKINETICS INC Director Sell 7.5 -15,000 -68.92% ✓ $675K
Dec 17, 2020 Dec 18, 2020 Stoke Therapeutics, Inc. CEO Sell 5.0 -25,000 -100.00% ✓ $1.5M
Nov 27, 2020 Nov 30, 2020 Stoke Therapeutics, Inc. CEO Sell 7.5 -12,152 -32.71% ✓ $607.6K
Nov 25, 2020 Nov 25, 2020 Stoke Therapeutics, Inc. CEO Sell 7.5 -12,848 -25.70% ✓ $642.4K
Oct 5, 2020 Oct 5, 2020 CYTOKINETICS INC Director Sell 7.5 -20,000 -100.00% ✓ $600K
Aug 3, 2017 Aug 7, 2017 Sarepta Therapeutics, Inc. Director Sell 40.0 -16,703 -19.00% ✗ $632.7K
Jul 20, 2017 Jul 21, 2017 Sarepta Therapeutics, Inc. Director Sell 12.5 -14,349 -21.47% ✓ $588K
Apr 20, 2017 Apr 24, 2017 Sarepta Therapeutics, Inc. CEO Sell 42.5 -4,349 -6.11% ✗ $141.5K
Jan 20, 2017 Jan 24, 2017 Sarepta Therapeutics, Inc. CEO Sell 42.5 -4,466 -5.90% ✗ $145.9K
Oct 20, 2016 Oct 24, 2016 Sarepta Therapeutics, Inc. CEO Sell 42.5 -4,348 -5.65% ✗ $213.3K
Sep 22, 2016 Sep 26, 2016 Sarepta Therapeutics, Inc. CEO Sell 5.0 -40,179 -34.29% ✓ $2.4M
Sep 19, 2016 Sep 21, 2016 Sarepta Therapeutics, Inc. CEO Sell 23.8 -24,352 -9.54% ✓ $1.2M
Sep 14, 2016 Sep 16, 2016 Sarepta Therapeutics, Inc. CEO Sell 12.5 -24,557 -24.18% ✓ $736.7K
Aug 31, 2016 Sep 2, 2016 Sarepta Therapeutics, Inc. CEO Sell 46.3 -1,487 -1.44% ✗ $38.8K
Jul 20, 2016 Jul 22, 2016 Sarepta Therapeutics, Inc. CEO Sell 42.5 -3,001 -2.83% ✗ $67.4K
Apr 20, 2016 Apr 22, 2016 Sarepta Therapeutics, Inc. CEO Sell 42.5 -3,001 -2.75% ✗ $59.1K
Jan 20, 2016 Jan 25, 2016 Sarepta Therapeutics, Inc. CEO Sell 46.3 -3,368 -3.15% ✗ $44.7K
Oct 20, 2015 Oct 22, 2015 Sarepta Therapeutics, Inc. CEO Sell 42.5 -3,001 -2.73% ✗ $80.2K
Jul 20, 2015 Jul 31, 2015 Sarepta Therapeutics, Inc. CEO Sell 42.5 -3,000 -2.68% ✗ $100.4K
Feb 27, 2015 Mar 3, 2015 Sarepta Therapeutics, Inc. SVP & Chief Medical Officer Buy 90.0 +800 156.56% ✗ $9.5K